Nicole Teusch
15Patents
3h-index
56Co-inventors
59Inventor score
Filing activity: Jan 18, 2006 → Jan 6, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8648069B2 | 5-substituted indazoles as kinase inhibitors | Chemistry; Metallurgy | 41 | Active |
| US9163007B2 | 5-substituted indazoles as kinase inhibitors | Chemistry; Metallurgy | 8 | Active |
| US8445686B2 | 4-(4-pyridinyl)-benzamides and their use as rock activity modulators | Chemistry; Metallurgy | 3 | Active |
| US9291621B2 | AGER-peptides and use thereof | Physics | 2 | Active |
| US8895749B2 | 4-(4-pyridinyl)-benzamides and their use as rock activity modulators | Chemistry; Metallurgy | 1 | Active |
| US8551989B2 | Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof | Human Necessities | 0 | Active |
| US9073939B2 | Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof | Human Necessities | 0 | Active |
| US8642595B2 | Annellated 4-(indazolyl)-1,4-dihydropyridine derivatives and methods of use thereof | Human Necessities | 0 | Active |
| US9255146B2 | Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9422263B2 | Fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof | Human Necessities | 0 | Active |
| US8604028B2 | Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US8759341B2 | Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9018234B2 | Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US7906120B2 | Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) | Emerging Cross-Sectional Technologies | 0 | Active |
| US10040852B2 | Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.